Pieris-AG

Welcome to Pieris

Pieris is developing Anticalin® product candidates to help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need.

Partnerships

Pieris’ platform provides broad potential for attractive products and partnerships in immuno-oncology and other indications. Pieris is open to discussing partnering opportunities around its existing proprietary programs and new drug discovery partnerships.

Learn more on how to partner with Pieris »

News

04/4/17

Pieris Pharmaceuticals Presents IND-enabling Data for Bispecific Immuno-Oncology Drug Candidate, PRS-343, in Poster Session at the 2017 Meeting of the American Association for Cancer Research (AACR)

Read More »
Pieris Pharmaceuticals, Inc. Investor Presentation

Investor Presentation

Pieris Pharmaceuticals, Inc.

Fact Sheet

Stock Info

NASDAQ
PIRS
Change
Volume
Market Cap
Email Alerts